Like Kevin Costner in Field of Dreams, Paul Travers was a little ahead of himself when he started Vuzix. There must have been a voice in his head saying, "if you build it, they will buy," because he kept...
Here in the United States, Bitcoin is the rage. It’s all over the news, everyone is talking about it, and fortunes are being made in ICOs and other digital currency derivatives. It’s likely a bubble, but it’s definitely the...
Tailwinds' Take: another positive step towards an approved product. As what would be the only product in a multi-billion market, the VenoValve has the potential to drive HJLI shares significantly over the next year as it moves down the...
What a difference a week makes. Two weeks ago the air was one with despair. Stocks bonds, the dollar, Bitcoin...all were crashing down around us. Then the stock market put up its best week since 2013, the dollar bounced,...
IRVINE, Calif., March 6, 2018 /PRNewswire/ -- Cryoport, Inc. (CYRX) (CYRXW) ("Cryoport" or the "Company"), the global leader in temperature-controlled logistics dedicated to the life sciences industry, today announced financial results for the three and twelve-month periods ended December 31, 2017. Jerrell Shelton,...
Two weeks ago I made an adjustment to the grips on my mountain bike. Rolled them forward a little bit. I had been feeling a little numb on the downhills and rumor was this would create the proper alignment,...
Tailwinds' Take: this stock represents the definition of "tailwinds". They have a very large secular move happening underneath them and they are the only option when it comes to shipping these therapeutics, so are a direct beneficiary of all...
Tailwinds' Take: good news that the offering has exceeded the minimum. An uplisting to Nasdaq will hopefully help take this stock to a valuation more in line with its peers. We still see this as a buyout candidate at...
Tailwinds' Take: very positive. Once this transaction closes, expect a PR detailing the accretion. A great value with strong growth coming through their acquisition strategy. SOMERSET, N.J., June 29, 2018 (GLOBE NEWSWIRE) -- MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider...
For the past few years modifying T-Cells to express Chimeric Antigen Receptors, a practice known as “CAR-T”,  has been the hottest space in cancer therapy. Through CAR-T therapy, there have been amazing strides made in saving patients suffering from...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.